US FDA Declined Topical Gel of Amryt for Rare Skin Diseases
On Monday, 28th February 2022, the company ‘Amryt’ said, the Food and Drug Administration (FDA) of the United States has declined to approve the drug of the company for the treatment of a group of the rare skin diseases called as the epidermolysis bullosa, and the agency has also asked Amryt for the purpose of […]
Continue Reading